At F1000, we are today announcing a new fully Open Access publishing program across biology and medicine, F1000 Research, which will launch later this year. It is intended to address the major issues afflicting scientific publishing today: timely dissemination of research, peer review, and sharing of data.
Helping researchers share their research more quickly.
F1000 founder and chairman Vitek Tracz addresses a former Faculty Member’s critique of our subscription service.
New horizons in open source science using online scientific research communities.
With a tobacco giant using freedom of information laws to access smoking study data, we ask the question – how much of scientific research should be accessible?
F1000 chairman, Vitek Tracz, announces a new model for data publishing, with open peer review.
More reaction to the Select Committee’s report on peer review, released last week. The Royal Society of Chemistry uses the occasion to trump its “subject repository style journal”, RSC Advances. Their press release also reminds me that they have a freely available chemical database, ChemSpider–which appears to have come on in leaps and bounds since…
You might have seen that the UK government has released its Select Committee’s report on peer review in science. The chair of the committee, Andrew Miller MP, says that the “general oversight of research integrity in the UK [is] unsatisfactory and complacent.” Note that he doesn’t say that the research is unsatisfactory–simply the oversight. I…
Everybody’s at it. This time, it’s the turn of the venerable Company of Biologists—a Cambridge-based “non-profit organization whose objectives are the advancement and promotion of research in, and the study of, all branches of biology”. They publish a number of well-respected titles, including Development, Journal of Experimental Biology and one of my all-time favourites, the…
You’ve probably heard by now of the plan, cooked up between the Howard Hughes Medical Institute, the Wellcome Trust and the Max Planck Society, to launch a new, open access journal–as yet sans name, sans Editor-in-Chief and sans business plan. There seem to be more questions than answers surrounding the Journal With No Name, and…
